Universal Delivery Technology
TargaCell can provide delivery of all major types of stem cells used in heart repair using our proprietary proteins.
Safe & Efficient
We will provide a safe, efficient intravenous, stem cell delivery, without anesthesia or cardiac catheter.
Delivery & Retention
We deliver and retain these stem cells in the heart to expedite the repair of damaged tissue and restore function.
Get in touch today. Call us at +1 806 433 0795 or request an appointment online.
WHAT IS TARGACELL ?
TargaCell is a stem cell delivery company that can deliver 10X more stem cells to the heart and retain them there to dramatically
improve the repair of damaged heart tissue resulting from a heart attack.
improve the repair of damaged heart tissue resulting from a heart attack.
SENDING STEM CELLS TO THE HEART
TargaCell's proprietary, stem-cell-directing proteins are rapidly cleared from the body making it possible to treat heart patients more often, perhaps once or twice per week, to accelerate heart repair, or provide a "tune-up" after a few weeks or months, if needed.
Building a healthy community for all.
SCIENTIFIC ADVISORY BOARD
Image
Name
Designation
Short Description
Social Links
Phil Anevski, PhD
Manager R& D , Lee BioSolutions, expert in pharmaceutical manufacturing & biologic
Susan Ball-Kell, DVM, PhD
DVM, PhDs in Pathology and Environmental Toxicology, Michigan State University & founder Global Path Imaging & Consulting, LTD
Scott Burger, MD
Key Opinion Leader in cellular therapy manufacturing & global regulatory affairs; FDA consultant; Principal, Advanced Cell & Gene Therapy
Leslie Miller, MD
Key Opinion Leader & Renowned cardiologist specializing in regenerative medicine for heart failure & cardiac disease, stem cell & gene therapies for restoration of heart function; Expert Heart Failure & Cardiovascular Research, Baycare Health System, Tampa, FL
Dennis Nelson, PhD
Founder, President of MIM Software, Inc., global company providing practical clinical imaging solutions
Mark Pittenger, PhD
20+ years as stem cell biology scientist, MSCs & regenerative Medicine, internationally known speaker Consultant, Human Longevity; Former VP for Research, Osiris Therapeutics - identified key conditions for MSC adipogenic, chondrogenic & osteogenic differentiation and intracellular signaling pathways 1999 Science paper cited 16,000 times, established that MSCs were multipotent. Inventor on 15 US patents for MSCs & role in cardiac repair.
Gary Schaer, MD
Professor, Medicine; Director, Cardiac Research & Strategic Development, Rush University Medical Center Key Opinion Leader on interventional cardiology & cardiac stem cell therapies 200+ original articles, book chapters, editorials and abstracts
